Amsterdam institute for Immunology and Infectious diseases
AI&I news
VACCINATION IMPACT | Advancing Hepatitis C Vaccine Research at AI&IAt the Amsterdam Institute for Immunology and Infectious Diseases (AI&I), vaccination is one of three key research pillars, alongside PAIS and Immunomonitoring. Regularly, we highlight one of these areas, exploring essential knowledge, challenges, and real-world impact. In Q3 2026, our focus is on Vaccination. In collaboration with AI&I researcher Dr. Kwinten Sliepen, we share the story of how vaccination research at AI&I is making a difference.
VACCINATION RESEARCH | Challenges and Developments in Vaccination Research from Infectious Diseases to CancerAt the Amsterdam Institute for Immunology and Infectious Diseases (AI&I), we focus on three key research areas: Post-Acute Infection Syndromes (PAIS), Immunomonitoring, and Vaccination. Regularly, we highlight one of these areas, exploring essential knowledge, challenges, and real-world impact. In Q3 2026, our spotlight is on Vaccination. In this article, written in collaboration with AI&I researcher Prof. Joke den Haan, we explore the challenges and developments in vaccination research.
VACCINATION TOPIC 101 | With Marit van GilsAt the Amsterdam Institute for Immunology and Infectious Diseases (AI&I), we focus on three key research areas: Post-Acute Infection Syndromes (PAIS), Immunomonitoring, and Vaccination. Regularly, we highlight one of these areas, exploring essential knowledge, challenges, and real-world impact. In Q3 2026, our spotlight is on Vaccination. In this article, written in collaboration with AI&I researcher Marit van Gils, we explore the topic in depth.